文献速递炎症性肠病

溃疡性结肠炎达标治疗更新:一项系统综述

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

本系统综述检索了自STRIDE系统综述至2018年3月31日MEDLINE中评估STRIDE推荐治疗目标的文献,每个潜在目标检索返回超过200篇文章,由2名独立研究者筛选。文章总结了临床因素、患者报告结局、内镜、组织学、影像和生物标志物等证据,认为可优化各治疗目标的相对权重,更强调内镜和组织学目标而非临床或症状目标,但需新研究证明达标治疗策略能带来更好的长期结局。

要点

  • 自STRIDE推荐以来,新的证据不断积累,本综述对相关证据进行了总结。
  • 每个潜在治疗目标的文献检索返回超过200篇文章,由2名独立研究者筛选。
  • 作者认为可优化各治疗目标的相对权重,更强调内镜和组织学目标而非临床或症状目标。

核心结论

  • 作者认为,在溃疡性结肠炎治疗开发与改进中,不同治疗目标的相对权重可被优化,应更强调内镜和组织学目标而非临床或症状目标。
  • 作者指出,要实现这一演变,新研究必须证明达标治疗策略相比当前方法能带来更好的长期结局。

研究设计与样本

  • 系统综述,检索MEDLINE中自STRIDE系统综述时起至2018年3月31日发表、评估STRIDE推荐所识别潜在治疗目标的研究。
  • 每个潜在治疗目标的文献检索返回超过200篇文章,由2名独立研究者筛选相关研究。

主要发现

  • 每个潜在治疗目标的文献检索返回超过200篇文章,由2名独立研究者筛选相关研究。
  • 综述总结了临床因素、患者报告结局、内镜、组织学、影像和生物标志物等选定研究及其对治疗目标的启示。

局限性

  • 作者指出,要实现更强调内镜和组织学目标的演变,新研究必须证明达标治疗策略相比当前方法能带来更好的长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In 2015, the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program proposed shifting the therapeutic focus on ulcerative colitis (UC) toward altering the natural history of the disease course by regularly monitoring objective measurements of disease activity and tailoring treatment accordingly. The therapeutic paradigm shift was well received in the research community and is often cited. However, new evidence on optimal UC treatment targets continues to accumulate since the time of the STRIDE guidelines. This systematic review summarizes the evidence accrued since the STRIDE UC recommendations, discusses the barriers for adoption of treat-to-target approaches in clinical practice in UC, and suggests directions for future research. METHODS: We systematically reviewed MEDLINE for studies from the time of the STRIDE systematic review up to March 31, 2018, that assessed the potential treatment targets identified by the STRIDE recommendations. RESULTS: Each potential treatment target literature search returned > 200 articles, which were then reviewed by 2 independent investigators for relevant studies. Selected studies of clinical factors, patient-reported outcomes, endoscopy, histology, imaging, and biomarkers and implications on treatment targets are summarized. CONCLUSIONS: It appears that the relative weight given to different therapeutic targets in the development and improvement of UC treatments could be optimized, with an increased emphasis on endoscopic and histological targets over clinical or symptomatic targets. For this evolution to occur, however, new research has to demonstrate that the treat-to-target approach will deliver on the promise of better long-term outcomes compared with current approaches.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Ungaro R, Colombel JF, Lissoos T, et al. A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review. Am J Gastroenterol. 2019. PMID: 30908297. doi:10.14309/ajg.0000000000000183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。